Can’t understand your logic. Where ever we are listed, we will need to raise capital at some point to fund the business? Staying on the asx does not mean we will never have to raise or dilute. Anyway each to their own, but that makes no sense.
Everyone saying the SP is due to Joel etc is deluded.
What has the SP on ATAI, Compass, EMD, IMU, BOT, OPT or ANY OTHER spec biotech done in recent times?
It’s horrible to see but certainly helps to get your head around what is going on around you.
IHL Price at posting:
5.3¢ Sentiment: Buy Disclosure: Held
